{"id":"diseptal-b-","rwe":[{"pmid":"41906986","year":"2026","title":"Fibroin/sulfated alginate membranes containing exosomes of stem cells treated with B and Zn-doped hydroxyapatite for periosteal tissue engineering.","finding":"","journal":"Journal of materials chemistry. B","studyType":"Clinical Study"},{"pmid":"41906968","year":"2026","title":"Predictive value of gB2 antibodies for maternal-fetal transmission after primary cytomegalovirus infection treated with valacyclovir.","finding":"","journal":"Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology","studyType":"Clinical Study"},{"pmid":"41906955","year":"2026","title":"Migration at Boron Cage for Selective B-H Functionalization of nido-Carboranes.","finding":"","journal":"Angewandte Chemie (International ed. in English)","studyType":"Clinical Study"},{"pmid":"41906925","year":"2026","title":"Rhizobacteria-Induced Systemic Priming Against Fungal Pathogens Involves Hydroxycinnamic Acid Amides.","finding":"","journal":"Plant, cell & environment","studyType":"Clinical Study"},{"pmid":"41906916","year":"2026","title":"Organoboron Cycloarenes: Boron-Carbon Annulated Macrocyclic π-Systems.","finding":"","journal":"Angewandte Chemie (International ed. in English)","studyType":"Clinical Study"}],"tags":[{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"ecosystem":[],"mechanism":{"explanation":"Imagine your body's cells are like locks, and proteins are like keys. Diseptal B is like a special key that fits into a specific lock, changing the way the lock works to help the body function better. This can help to treat various diseases, but more research is needed to understand how it works and what it treats.","oneSentence":"Diseptal B works by binding to a specific protein or receptor in the body, altering its function to produce a therapeutic effect.","technicalDetail":"Diseptal B's mechanism of action involves a specific interaction with a protein or receptor, potentially modulating downstream signaling pathways to produce its therapeutic effect."},"references":[{"id":1,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=diseptal B","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:47:29.387280","biosimilars":[],"competitors":[],"genericName":"diseptal b","drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1642283,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar 30","pmid":"41906986","title":"Fibroin/sulfated alginate membranes containing exosomes of stem cells treated with B and Zn-doped hydroxyapatite for periosteal tissue engineering.","journal":"Journal of materials chemistry. B"},{"date":"2026 Mar 30","pmid":"41906968","title":"Predictive value of gB2 antibodies for maternal-fetal transmission after primary cytomegalovirus infection treated with valacyclovir.","journal":"Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology"},{"date":"2026 Mar 30","pmid":"41906955","title":"Migration at Boron Cage for Selective B-H Functionalization of nido-Carboranes.","journal":"Angewandte Chemie (International ed. in English)"},{"date":"2026 Mar 30","pmid":"41906925","title":"Rhizobacteria-Induced Systemic Priming Against Fungal Pathogens Involves Hydroxycinnamic Acid Amides.","journal":"Plant, cell & environment"},{"date":"2026 Mar 30","pmid":"41906916","title":"Organoboron Cycloarenes: Boron-Carbon Annulated Macrocyclic π-Systems.","journal":"Angewandte Chemie (International ed. in English)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"diseptal B ","companyName":"","companyId":"unknown","modality":"","firstApprovalDate":"","aiSummary":"Diseptal B is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a result, there is limited information available about its pharmacokinetic properties, such as half-life and bioavailability. Further research is needed to determine its potential therapeutic applications and safety profile. The current owner of Diseptal B is unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}